M12.25 Villonodular synovitis (pigmented), hip

Name of the Condition

• Villonodular synovitis (pigmented), hip (ICD-10 Code: M12.25)

Summary

Villonodular synovitis (pigmented), hip is a rare, benign proliferative disorder of the synovium (joint lining) characterized by abnormal growth of tissue and hemosiderin deposition. It typically presents as localized joint swelling and pain, often affecting the hip joint. The condition is non-malignant but may cause functional impairment due to mechanical obstruction or joint damage.

Causes

The exact cause is unknown, but it is thought to arise from a reactive or inflammatory process within the synovium. Trauma, chronic irritation, or abnormal blood vessel formation may contribute to the development of the proliferative tissue. The pigmented appearance is due to hemosiderin, a byproduct of old blood, deposited in the synovial tissue.

Risk Factors

• Previous joint injury or surgery.
• Chronic joint inflammation or irritation.
• Age: More common in young to middle-aged adults.
• Gender: Slightly more prevalent in males.

Symptoms

• Persistent joint swelling, often painless or mildly painful.
• Limited range of motion or stiffness in the affected hip.
• Palpable mass or nodule within the joint.
• Recurrent effusions (fluid buildup) in the joint.

Diagnosis

Physical examination to assess joint swelling, tenderness, or range of motion. Imaging tests such as MRI or ultrasound may be used to evaluate soft tissue changes. Biopsy of the synovial tissue may be performed to confirm the diagnosis by identifying hemosiderin deposition and proliferative tissue.

Treatment Options

Treatment may include surgical removal of the abnormal tissue (synovectomy) to relieve symptoms and prevent recurrence. Non-surgical options, such as physical therapy or anti-inflammatory medications, may be considered for mild cases. Post-surgical rehabilitation is often recommended to restore mobility.

Prognosis and Follow-Up

Prognosis is generally good with appropriate treatment, though recurrence is possible. Regular follow-up may be necessary to monitor for recurrence or complications. Long-term outcomes depend on the extent of joint involvement and response to treatment.

Complications

Potential complications include joint stiffness, persistent pain, or recurrence of the condition. In rare cases, untreated or recurrent cases may lead to joint degeneration or limited mobility.

Lifestyle & Prevention

Avoiding excessive joint stress or trauma may help reduce risk. Maintaining a healthy weight and engaging in low-impact activities can support joint health. Prompt treatment of joint injuries or inflammation may prevent progression.

When to Seek Professional Help

Seek medical attention if you experience persistent hip pain, swelling, or limited mobility that does not improve with rest or over-the-counter treatments. Early evaluation is important to prevent complications.

Tips for Medical Coders

Document the specific joint involvement (hip) and confirm the presence of pigmented features (hemosiderin deposition) to support the M12.25 code. Ensure clinical documentation aligns with the diagnosis, including details of imaging or biopsy results if available.